Dara Cohen, a graduate of the Albert Einstein College of Medicine, completed her internship and residency at Cedars Sinai Medical Center in Los Angeles, CA. She returned to New York in 2009 to pursue a postdoctoral research fellowship and a clinical fellowship in Endocrinology, Diabetes and Metabolism at Mount Sinai. During her training, she was involved in several research projects focusing on the connection between diabetes and cancer.
Her clinical interests include Type 1 and Type 2 Diabetes, Gestational Diabetes, thyroid disease, adrenal disorders, bone diseases and female reproductive disorders.
Alpha Omega Alpha
Alpha Omega Alpha
Glasgow-Rubin Achievement Citation
American Medical Women's Association
Cohen D, LeRoith D. Obesity, Type 2 Diabetes & Cancer: The Insulin & Insulin-Like Growth Factor Connection. Endocrine Related Cancer (in press).;.
Cannata D, Kirschenbaum A, Levine A. Clinical Case Seminar: Androgen Deprivation Therapy as Primary Treatment for Prostate Cancer. JCEM 2012 February;: 360-5.
Ferguson R, Alikhani N, Vijayakumar A, Fierz Y, Cannata D, Yakar S. IGF-1 Cellular Action and its Relationship to Cancer: Evidence from in Vitro and in Vivo Studies. Springer Science+Business Media 2012;.
Elis S, Wu Y, Courtland H, Cannata D, Sun H, Beth-On M, Liu C, Jasper H, Domené H, Karabatas L, Guida C, Basta-Pljakic J, Cardoso L, Rosen C, Frystyk J, Yakar S. IGF1 enhances somatic growth. Dis Model Mech 2011 Sept-Oct;.
Lann D, Wu Y, Elis S, Yakar S, Cannata D, Lazzarino D, Wood T, LeRoith D. Elevated circulating IGF-I promotes mammary gland development and proliferation. Endocrinology 2010 December; 151(12): 5751-61.
Cannata D, Fierz Y, Vijayakumar A, LeRoith D. Type 2 diabetes and cancer: what is the connection? . Mt Sinai J Med 2010; 2(77): 197-213.
Cannata Y, Vijayakumar A, Fierz Y, LeRoith L. The GH/IGF-I axis in growth and development: New insights derived from animal models. Adv Pediatr 2010;: 331-51.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Cohen is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.